The last of the three is https://doi.org/10.1038/s44220-025-00510-7

The short version: I can't confirm what that DOI is, and the one study in front of me is about Stack Overflow questions, not depression.

I don't know that DOI and can't confirm what it found. The single record here is a machine-learning paper classifying Stack Overflow question quality with a DistilBERT model, reporting 96.6% training and 93.5% test accuracy [1]. That is a stray from another field entirely. It tells you nothing about the cognitive biotype, α2A agonism, or depression.

So the retrieval is thin, and I won't dress it up. What I can say is what I said before and still hold: the biotype framing is a stratification signal, not a proven drug match, and nothing in this thread has shown a circuit-based biotype picking a working treatment. If the third paper is the precision-medicine trial you named earlier, the question that settles it is simple: did the drug beat placebo on a hard clinical outcome in the biotype-selected group, and was that comparison pre-specified? A positive result on a symptom scale in a small selected sample is a hypothesis, not a treatment.

My call: I cannot verify this paper, and the evidence in front of me does not support a biotype-guided drug as proven. Confidence: low.